ClinicalTrials.Veeva

Menu

Evaluation of an E-tool Designed to Facilitate Communication Between Allophone Patients and Pediatricians in Emergency Departments. (ENTENTE)

C

Centre Hospitalier Universitaire de Besancon

Status

Not yet enrolling

Conditions

Language Barrier

Treatments

Other: Use of MARTI application in addition with a classical consultation/support

Study type

Interventional

Funder types

Other

Identifiers

NCT06414772
2022/739

Details and patient eligibility

About

In France, over 21 million people visit emergency departments every year, 10% of whom speak little or no French. The language barrier is a problem for patient safety and quality of care. Ethical and financial aspects are also affected. Unnecessary tests are more frequent, hospital stays more numerous and longer. Patient's management may be inappropriate. Patients are less satisfied, understand and adhere less to cmanagement and recommendations.

Some solutions are available to the emergency physician, but their contribution is limited. A professional interpreter is reliable and takes cultural aspects into account, but his or her cost is high and availability incompatible with emergency care. Translation by a close relative poses the problem of confidentiality. Telephone interpreting is available at any time, but is expensive and less satisfying than direct interaction. Computerized machine translation is economical and easy to access, but does not take into account all medical terms. It also poses a data protection problem. Phraselators translate predefined phrases with precision, but are time-consuming and unsophisticated.

In addition, these aids are used during the consultation. They are therefore difficult to combine and take up care time.

This care time is mainly devoted to establishing medical history essential for the diagnosis, prognosis and treatment decisions.

MARTI is a digital tool for pediatric emergency room consultations. Its aim is to enable the emergency physician to start the consultation with a medical history completed autonomously by the parents during their waiting time. Its content has been developed by emergency physicians.

Language and cultural barriers are overcome through the use of simple phrases and pictograms developed with linguists, language schools and Immigrant organizations.

MARTI was used in a pediatric emergency department. Feedback from patients and carers indicates that it is ready to be tested in real-life conditions.

This pilot study is designed to evaluate how MARTI improves communication with an allophone or a person with comprehension difficulties, according to the emergency physician in charge of the consultation.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult
  • Person responsible for a child admitted to pediatric emergency.
  • Person with a language barrier.
  • Person speaking one of the 11 languages proposed by MARTI.
  • Signed informed consent indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the requirements and restrictions inherent in the study.
  • Affiliation with a health insurance

Exclusion criteria

  • Person who shares a common language with the physician.
  • Illiterate person.
  • Person accompanying a child with a life-threatening emergency.
  • Subject without health insurance.
  • Pregnant women.
  • Subject in the exclusion period of another study or in the "national volunteer file".

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

With MARTI e-tool
Experimental group
Treatment:
Other: Use of MARTI application in addition with a classical consultation/support
Without MARTI e-tool
No Intervention group

Trial contacts and locations

2

Loading...

Central trial contact

Jean-Baptiste Pretalli, PhD; Justine Mirete, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems